Page last updated: 2024-10-31

neostigmine and Empyema

neostigmine has been researched along with Empyema in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Empyema: Presence of pus in a hollow organ or body cavity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ZISLIN, BD1
FORSHTADT, VM1
LYSKOV, PG1
TURBINA, NV1

Other Studies

1 other study available for neostigmine and Empyema

ArticleYear
[ON CARDIAC RHYTHM CONTROL IN PULMONARY AND PLEURAL SURGERY].
    Vestnik khirurgii imeni I. I. Grekova, 1964, Volume: 92

    Topics: Cardiac Complexes, Premature; Empyema; Empyema, Tuberculous; Humans; Neostigmine; Pacemaker, Artific

1964